Is Nurix Therapeutics Inc (NASDAQ: NRIX) Still On The Rise?

Jeremiah Abramson

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.

Stocks Info

This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Nurix Therapeutics Inc is $1.99B. A total of 1.96 million shares were traded on the day, compared to an average of 1.64M shares.

In the most recent transaction, Ring Christine sold 37,600 shares of NRIX for 17.07 per share on Nov 24 ’25. After the transaction, the Chief Legal Officer now owns 50,897 company shares. In a previous transaction on Nov 24 ’25, CHRISTINE RING bought 37,600 shares at 16.76 per share.

Among the insiders who sold shares, van Houte Hans disposed of 6,284 shares on Nov 03 ’25 at a per-share price of $12.56. This resulted in the Chief Financial Officer holding 37,592 shares of NRIX after the transaction. In another insider transaction, JOHANNES VAN HOUTE bought 6,284 shares at $12.94 per share on Nov 03 ’25.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, NRIX has a high of $22.95 and a low of $8.18.

As of this writing, NRIX has an earnings estimate of -$0.92 per share for the current quarter. EPS was calculated based on a consensus of 12.0 estimates, with a high estimate of -$0.72 per share and a lower estimate of -$1.15. The company reported an EPS of -$0.75 in the last quarter

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. NRIX’s latest balance sheet shows that the firm has $295.72M in Cash & Short Term Investments as of fiscal 2021. There were $13.04M in debt and $66.26M in liabilities at the time. Its Book Value Per Share was $4.84, while its Total Shareholder’s Equity was $342.30M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NRIX is Buy with a score of 4.58.

Park Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.